Gene Symbol | Gene ID | Gene Info |
---|---|---|
Atf1
|
ENSMUSG00000023027.6 | activating transcription factor 1 |
Creb5
|
ENSMUSG00000053007.6 | cAMP responsive element binding protein 5 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_100227111_100227300 | Atf1 | 614 | 0.648598 | -0.88 | 4.9e-19 | Click! |
chr15_100227363_100228534 | Atf1 | 77 | 0.959942 | -0.71 | 9.0e-10 | Click! |
chr15_100228567_100228718 | Atf1 | 379 | 0.808630 | -0.52 | 4.2e-05 | Click! |
chr15_100259166_100259317 | Atf1 | 5026 | 0.139813 | -0.48 | 2.0e-04 | Click! |
chr15_100232101_100232252 | Atf1 | 5 | 0.967906 | -0.33 | 1.5e-02 | Click! |
chr6_53573821_53573972 | Creb5 | 520 | 0.859454 | 0.79 | 1.1e-12 | Click! |
chr6_53545517_53545668 | Creb5 | 27708 | 0.227821 | 0.75 | 3.0e-11 | Click! |
chr6_53583369_53583554 | Creb5 | 10085 | 0.270993 | 0.74 | 8.1e-11 | Click! |
chr6_53545704_53545864 | Creb5 | 27516 | 0.228403 | 0.71 | 1.3e-09 | Click! |
chr6_53593787_53593938 | Creb5 | 20486 | 0.238683 | 0.69 | 4.7e-09 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_61225302_61226760 | 145.95 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr12_3236518_3237725 | 54.91 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr14_14350947_14351733 | 41.37 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr19_61228253_61228788 | 30.83 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
91 |
0.95 |
chr14_14347096_14348750 | 28.22 |
Gm48860 |
predicted gene, 48860 |
659 |
0.44 |
chr5_109556763_109557843 | 27.72 |
Crlf2 |
cytokine receptor-like factor 2 |
830 |
0.53 |
chrX_170673967_170674476 | 27.57 |
Asmt |
acetylserotonin O-methyltransferase |
1577 |
0.54 |
chr3_69709128_69709981 | 27.41 |
Rpl32-ps |
ribosomal protein L32, pseudogene |
7839 |
0.17 |
chr4_3067329_3068553 | 26.23 |
Gm27878 |
predicted gene, 27878 |
16122 |
0.2 |
chr9_124439906_124440949 | 22.92 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr15_84105394_84105979 | 21.50 |
Sult4a1 |
sulfotransferase family 4A, member 1 |
68 |
0.93 |
chr19_61226764_61227156 | 17.87 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
276 |
0.86 |
chr6_53286985_53287825 | 16.95 |
Creb5 |
cAMP responsive element binding protein 5 |
77 |
0.98 |
chr16_42444648_42444859 | 16.52 |
Gap43 |
growth associated protein 43 |
104102 |
0.07 |
chr5_32713265_32714499 | 16.24 |
Gm43852 |
predicted gene 43852 |
106 |
0.94 |
chrX_143664216_143664417 | 15.82 |
Pak3 |
p21 (RAC1) activated kinase 3 |
26 |
0.99 |
chr2_49619191_49619386 | 15.67 |
Kif5c |
kinesin family member 5C |
10 |
0.99 |
chr8_4677704_4678740 | 15.49 |
Gm7461 |
predicted gene 7461 |
143 |
0.62 |
chr13_54687539_54688580 | 15.47 |
Rnf44 |
ring finger protein 44 |
35 |
0.96 |
chr9_124425594_124425957 | 15.36 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
1621 |
0.32 |
chr5_104109154_104109490 | 15.34 |
Gm26703 |
predicted gene, 26703 |
31 |
0.96 |
chr14_63756121_63756555 | 15.13 |
Mir598 |
microRNA 598 |
29149 |
0.17 |
chr7_31127074_31128340 | 15.01 |
Scn1b |
sodium channel, voltage-gated, type I, beta |
704 |
0.47 |
chr12_92247060_92247465 | 14.75 |
Gm6841 |
predicted gene 6841 |
27885 |
0.23 |
chr17_56475522_56476833 | 14.71 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
192 |
0.93 |
chr18_35214941_35215148 | 14.66 |
Lrrtm2 |
leucine rich repeat transmembrane neuronal 2 |
20 |
0.56 |
chr16_38940798_38940949 | 14.64 |
Gm22500 |
predicted gene, 22500 |
13664 |
0.21 |
chr2_127521161_127522051 | 14.56 |
Kcnip3 |
Kv channel interacting protein 3, calsenilin |
236 |
0.88 |
chr14_14349400_14349589 | 14.41 |
Il3ra |
interleukin 3 receptor, alpha chain |
127 |
0.93 |
chr7_79499656_79500079 | 14.36 |
Mir9-3hg |
Mir9-3 host gene |
159 |
0.9 |
chrX_170675926_170676102 | 13.81 |
Asmt |
acetylserotonin O-methyltransferase |
3370 |
0.36 |
chr12_3238767_3239202 | 13.64 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
2373 |
0.24 |
chr16_43464263_43464471 | 13.33 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
39247 |
0.15 |
chr5_150906447_150906658 | 13.17 |
Gm43298 |
predicted gene 43298 |
23910 |
0.17 |
chr11_84042951_84043150 | 12.86 |
Synrg |
synergin, gamma |
16395 |
0.16 |
chrX_111696678_111697295 | 12.82 |
Hdx |
highly divergent homeobox |
93 |
0.98 |
chr3_17793443_17793892 | 12.70 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
253 |
0.9 |
chr13_78181984_78182157 | 12.66 |
Gm38604 |
predicted gene, 38604 |
1089 |
0.41 |
chr13_55471184_55472974 | 12.63 |
Mir6944 |
microRNA 6944 |
5697 |
0.08 |
chr17_50407363_50407533 | 12.52 |
Gm49906 |
predicted gene, 49906 |
68196 |
0.11 |
chr9_91350886_91351318 | 12.29 |
A730094K22Rik |
RIKEN cDNA A730094K22 gene |
149 |
0.92 |
chr3_84305830_84305981 | 12.22 |
Trim2 |
tripartite motif-containing 2 |
459 |
0.87 |
chr4_151141102_151141464 | 12.19 |
Camta1 |
calmodulin binding transcription activator 1 |
1699 |
0.42 |
chr13_46006832_46006993 | 11.84 |
5033430I15Rik |
RIKEN cDNA 5033430I15 gene |
41561 |
0.14 |
chr6_6163092_6163256 | 11.72 |
Slc25a13 |
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13 |
10777 |
0.26 |
chrX_66652851_66653188 | 11.69 |
Slitrk2 |
SLIT and NTRK-like family, member 2 |
12 |
0.98 |
chr11_118748779_118748930 | 11.51 |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
12187 |
0.22 |
chr2_14589660_14589811 | 11.49 |
Cacnb2 |
calcium channel, voltage-dependent, beta 2 subunit |
13353 |
0.13 |
chr4_124485041_124485232 | 11.47 |
1700057H15Rik |
RIKEN cDNA 1700057H15 gene |
823 |
0.67 |
chr14_14349604_14349813 | 11.41 |
Il3ra |
interleukin 3 receptor, alpha chain |
87 |
0.94 |
chr9_40268412_40269319 | 11.39 |
Scn3b |
sodium channel, voltage-gated, type III, beta |
352 |
0.82 |
chr19_53740861_53741021 | 11.35 |
Gm16298 |
predicted gene 16298 |
27369 |
0.16 |
chr10_110088757_110088908 | 11.07 |
Gm47337 |
predicted gene, 47337 |
10141 |
0.19 |
chr9_111762963_111763157 | 11.06 |
Stac |
src homology three (SH3) and cysteine rich domain |
72712 |
0.11 |
chr2_180892991_180893395 | 11.05 |
Mir124a-3 |
microRNA 124a-3 |
847 |
0.31 |
chr1_73270841_73271081 | 10.98 |
Gm29185 |
predicted gene 29185 |
1897 |
0.38 |
chr13_84571404_84571594 | 10.94 |
Gm26913 |
predicted gene, 26913 |
119442 |
0.06 |
chr5_107497460_107497812 | 10.86 |
Btbd8 |
BTB (POZ) domain containing 8 |
140 |
0.93 |
chr4_76450675_76450993 | 10.79 |
Gm42303 |
predicted gene, 42303 |
397 |
0.73 |
chr6_55680988_55681310 | 10.78 |
Neurod6 |
neurogenic differentiation 6 |
114 |
0.97 |
chr14_66343930_66344374 | 10.71 |
Stmn4 |
stathmin-like 4 |
144 |
0.95 |
chr6_6862606_6862972 | 10.63 |
Dlx6 |
distal-less homeobox 6 |
545 |
0.57 |
chr10_3863520_3864007 | 10.62 |
Gm16149 |
predicted gene 16149 |
5844 |
0.21 |
chr13_6131432_6131800 | 10.61 |
Gm47548 |
predicted gene, 47548 |
57834 |
0.13 |
chr16_85139441_85139618 | 10.59 |
Gm49226 |
predicted gene, 49226 |
9300 |
0.19 |
chr13_84449354_84449551 | 10.50 |
Gm26927 |
predicted gene, 26927 |
109339 |
0.06 |
chr8_65617940_65618821 | 10.49 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
145 |
0.97 |
chr17_78454364_78454515 | 10.44 |
Gm19399 |
predicted gene, 19399 |
4206 |
0.19 |
chr15_32002923_32003126 | 10.44 |
Gm49285 |
predicted gene, 49285 |
46927 |
0.18 |
chr6_6603963_6604155 | 10.43 |
Sem1 |
SEM1, 26S proteasome complex subunit |
25396 |
0.18 |
chr4_141335224_141335761 | 10.41 |
Gm25690 |
predicted gene, 25690 |
10672 |
0.09 |
chr10_42941967_42942282 | 10.40 |
Scml4 |
Scm polycomb group protein like 4 |
2243 |
0.3 |
chr12_111758304_111760062 | 10.30 |
Klc1 |
kinesin light chain 1 |
170 |
0.91 |
chr4_3082761_3083956 | 10.30 |
Vmn1r-ps2 |
vomeronasal 1 receptor, pseudogene 2 |
21234 |
0.18 |
chr1_33907825_33908362 | 10.28 |
Dst |
dystonin |
132 |
0.68 |
chr9_108824703_108825009 | 10.26 |
Gm35025 |
predicted gene, 35025 |
5 |
0.87 |
chr16_29837376_29837556 | 10.25 |
Gm32679 |
predicted gene, 32679 |
2738 |
0.29 |
chr2_158409115_158410592 | 10.21 |
Ralgapb |
Ral GTPase activating protein, beta subunit (non-catalytic) |
0 |
0.95 |
chr1_169485704_169485889 | 10.13 |
Gm5265 |
predicted pseudogene 5265 |
31927 |
0.17 |
chr6_39871251_39871962 | 10.10 |
Tmem178b |
transmembrane protein 178B |
145 |
0.75 |
chr1_79439956_79440337 | 10.08 |
Scg2 |
secretogranin II |
26 |
0.98 |
chr8_95703143_95704225 | 10.05 |
Ndrg4 |
N-myc downstream regulated gene 4 |
614 |
0.57 |
chr12_27083107_27083496 | 10.02 |
Gm9866 |
predicted gene 9866 |
31694 |
0.24 |
chr13_67332113_67332845 | 9.92 |
Zfp595 |
zinc finger protein 595 |
21 |
0.94 |
chr14_100461560_100461847 | 9.88 |
6330576A10Rik |
RIKEN cDNA 6330576A10 gene |
2280 |
0.32 |
chr5_137152605_137152797 | 9.88 |
Muc3 |
mucin 3, intestinal |
3379 |
0.13 |
chr2_138406228_138406429 | 9.84 |
Btbd3 |
BTB (POZ) domain containing 3 |
127835 |
0.06 |
chr13_8995529_8996265 | 9.83 |
Gtpbp4 |
GTP binding protein 4 |
153 |
0.91 |
chr3_49593115_49593458 | 9.79 |
Gm38261 |
predicted gene, 38261 |
10275 |
0.16 |
chr11_43747463_43748363 | 9.79 |
Ttc1 |
tetratricopeptide repeat domain 1 |
69 |
0.98 |
chr2_178141291_178141933 | 9.73 |
Phactr3 |
phosphatase and actin regulator 3 |
321 |
0.92 |
chr5_89763970_89764289 | 9.71 |
Gm25758 |
predicted gene, 25758 |
64742 |
0.13 |
chrX_8145632_8146303 | 9.71 |
Rbm3os |
RNA binding motif protein 3, opposite strand |
50 |
0.53 |
chr11_68564472_68564664 | 9.71 |
Mfsd6l |
major facilitator superfamily domain containing 6-like |
8382 |
0.15 |
chr13_100892908_100893059 | 9.71 |
Gm41041 |
predicted gene, 41041 |
16906 |
0.14 |
chr13_68997784_68997935 | 9.68 |
Gm48593 |
predicted gene, 48593 |
160 |
0.89 |
chr1_121226583_121227159 | 9.60 |
Gm29359 |
predicted gene 29359 |
2595 |
0.33 |
chr9_14031471_14031650 | 9.60 |
1700019J19Rik |
RIKEN cDNA 1700019J19 gene |
58060 |
0.11 |
chr2_66180561_66180718 | 9.51 |
Gm13618 |
predicted gene 13618 |
7197 |
0.19 |
chr12_47164470_47164875 | 9.46 |
Gm36971 |
predicted gene, 36971 |
370 |
0.91 |
chr2_49570527_49570718 | 9.44 |
Epc2 |
enhancer of polycomb homolog 2 |
41747 |
0.16 |
chrX_102003725_102004324 | 9.43 |
Nhsl2 |
NHS-like 2 |
1020 |
0.5 |
chr15_95428379_95428562 | 9.36 |
Nell2 |
NEL-like 2 |
99708 |
0.08 |
chr15_38374820_38375240 | 9.33 |
Gm41307 |
predicted gene, 41307 |
29124 |
0.13 |
chr3_34231745_34231896 | 9.31 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
34956 |
0.16 |
chr14_54772397_54772574 | 9.26 |
Slc7a8 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 8 |
9445 |
0.1 |
chr13_101233830_101234007 | 9.24 |
5930438M14Rik |
RIKEN cDNA 5930438M14 gene |
1791 |
0.4 |
chr7_63445460_63445631 | 9.23 |
Otud7a |
OTU domain containing 7A |
768 |
0.51 |
chrX_170675440_170675591 | 9.09 |
Asmt |
acetylserotonin O-methyltransferase |
2871 |
0.39 |
chr2_167777338_167778099 | 9.08 |
Gm14321 |
predicted gene 14321 |
182 |
0.93 |
chr3_88214175_88214875 | 9.08 |
Gm3764 |
predicted gene 3764 |
30 |
0.87 |
chr12_12684977_12685317 | 9.02 |
Gm27952 |
predicted gene, 27952 |
2529 |
0.25 |
chr7_79504714_79505014 | 9.02 |
Mir9-3 |
microRNA 9-3 |
400 |
0.7 |
chr8_54163625_54163799 | 9.01 |
Vegfc |
vascular endothelial growth factor C |
85933 |
0.1 |
chr13_60085093_60085249 | 8.90 |
Gm48397 |
predicted gene, 48397 |
16530 |
0.15 |
chr19_61227192_61227555 | 8.89 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
3 |
0.96 |
chr9_58009055_58009265 | 8.87 |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
2749 |
0.19 |
chr11_98959522_98960759 | 8.81 |
Rara |
retinoic acid receptor, alpha |
272 |
0.84 |
chr11_6605194_6605847 | 8.75 |
Nacad |
NAC alpha domain containing |
533 |
0.58 |
chr10_29211538_29211883 | 8.73 |
9330159F19Rik |
RIKEN cDNA 9330159F19 gene |
5 |
0.97 |
chr9_45055062_45055695 | 8.66 |
Gm48840 |
predicted gene, 48840 |
34 |
0.66 |
chr4_130107405_130108126 | 8.66 |
Pef1 |
penta-EF hand domain containing 1 |
209 |
0.92 |
chr12_102554760_102554930 | 8.55 |
Chga |
chromogranin A |
124 |
0.96 |
chr7_63444022_63445137 | 8.51 |
4930554H23Rik |
RIKEN cDNA 4930554H23 gene |
50 |
0.67 |
chr9_52679712_52680046 | 8.49 |
Gm1715 |
predicted gene 1715 |
16 |
0.58 |
chr15_65455267_65455418 | 8.48 |
Gm49243 |
predicted gene, 49243 |
232806 |
0.02 |
chr14_9642748_9642899 | 8.47 |
Gm48371 |
predicted gene, 48371 |
173268 |
0.03 |
chr3_56478690_56478916 | 8.44 |
Gm25727 |
predicted gene, 25727 |
33391 |
0.24 |
chr7_19749021_19749968 | 8.43 |
Nectin2 |
nectin cell adhesion molecule 2 |
39 |
0.93 |
chr6_50566211_50567217 | 8.40 |
5430402O13Rik |
RIKEN cDNA 5430402O13 gene |
24 |
0.68 |
chr5_35454198_35454812 | 8.39 |
Gm43377 |
predicted gene 43377 |
58407 |
0.08 |
chr5_137152229_137152427 | 8.34 |
Muc3 |
mucin 3, intestinal |
3006 |
0.14 |
chr9_121403317_121403530 | 8.33 |
Trak1 |
trafficking protein, kinesin binding 1 |
55 |
0.98 |
chr13_41729696_41729998 | 8.30 |
Adtrp |
androgen dependent TFPI regulating protein |
70719 |
0.08 |
chr5_5431890_5432041 | 8.29 |
Cdk14 |
cyclin-dependent kinase 14 |
11653 |
0.19 |
chr7_84112843_84113005 | 8.29 |
Cemip |
cell migration inducing protein, hyaluronan binding |
26422 |
0.14 |
chr19_48241092_48241255 | 8.20 |
Gm23857 |
predicted gene, 23857 |
528 |
0.84 |
chr9_118762868_118763019 | 8.19 |
Itga9 |
integrin alpha 9 |
44341 |
0.15 |
chr2_143545715_143546271 | 8.15 |
Pcsk2os1 |
proprotein convertase subtilisin/kexin type 2, opposite strand 1 |
16 |
0.67 |
chr7_109781147_109782179 | 8.15 |
Nrip3 |
nuclear receptor interacting protein 3 |
118 |
0.94 |
chrX_7639834_7640277 | 8.07 |
Syp |
synaptophysin |
294 |
0.76 |
chr13_35453420_35453571 | 8.03 |
Gm48703 |
predicted gene, 48703 |
58112 |
0.12 |
chr16_57302914_57303208 | 8.02 |
Tmem30c |
transmembrane protein 30C |
10196 |
0.14 |
chr12_54459580_54460031 | 8.01 |
Gm7557 |
predicted gene 7557 |
29407 |
0.13 |
chr1_87170311_87170503 | 7.98 |
Prss56 |
protease, serine 56 |
12906 |
0.09 |
chr18_82825557_82825751 | 7.97 |
4930445N18Rik |
RIKEN cDNA 4930445N18 gene |
30240 |
0.12 |
chr5_117242256_117242407 | 7.93 |
Taok3 |
TAO kinase 3 |
1871 |
0.27 |
chr16_46769423_46769582 | 7.91 |
Gm17900 |
predicted gene, 17900 |
231667 |
0.02 |
chr13_101233544_101233729 | 7.90 |
5930438M14Rik |
RIKEN cDNA 5930438M14 gene |
1509 |
0.45 |
chr8_80057499_80058156 | 7.90 |
Hhip |
Hedgehog-interacting protein |
179 |
0.95 |
chr3_128520668_128521062 | 7.88 |
Gm22293 |
predicted gene, 22293 |
19507 |
0.26 |
chr16_26316464_26316628 | 7.88 |
Cldn1 |
claudin 1 |
44248 |
0.19 |
chr13_41416055_41416367 | 7.87 |
Gm48570 |
predicted gene, 48570 |
13920 |
0.15 |
chr14_34505371_34505540 | 7.86 |
Bmpr1a |
bone morphogenetic protein receptor, type 1A |
2114 |
0.21 |
chr12_52010002_52010599 | 7.85 |
Dtd2 |
D-tyrosyl-tRNA deacylase 2 |
3799 |
0.19 |
chrX_21360794_21360997 | 7.85 |
Gm5124 |
predicted pseudogene 5124 |
30 |
0.98 |
chr5_105498686_105498837 | 7.82 |
Gm42141 |
predicted gene, 42141 |
3291 |
0.24 |
chr4_58677814_58677996 | 7.82 |
Gm12580 |
predicted gene 12580 |
19313 |
0.2 |
chr2_19909485_19909886 | 7.82 |
Etl4 |
enhancer trap locus 4 |
95 |
0.97 |
chr11_6528030_6529187 | 7.81 |
Snhg15 |
small nucleolar RNA host gene 15 |
155 |
0.75 |
chr9_55540834_55541188 | 7.79 |
Gm17226 |
predicted gene 17226 |
123 |
0.51 |
chr17_25560908_25561062 | 7.79 |
Gm50026 |
predicted gene, 50026 |
228 |
0.84 |
chr7_141060848_141061734 | 7.78 |
B4galnt4 |
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
74 |
0.93 |
chr12_9584580_9585090 | 7.77 |
Osr1 |
odd-skipped related transcription factor 1 |
10394 |
0.18 |
chr10_21144979_21145199 | 7.76 |
Gm26577 |
predicted gene, 26577 |
5 |
0.96 |
chr10_86492150_86492313 | 7.76 |
Syn3 |
synapsin III |
334 |
0.82 |
chr5_137313761_137314590 | 7.71 |
Trip6 |
thyroid hormone receptor interactor 6 |
11 |
0.94 |
chr6_28981268_28981880 | 7.67 |
Gm3294 |
predicted gene 3294 |
60 |
0.98 |
chr2_94246412_94247550 | 7.66 |
Mir670hg |
MIR670 host gene (non-protein coding) |
3643 |
0.17 |
chr17_24689202_24689794 | 7.64 |
Syngr3 |
synaptogyrin 3 |
457 |
0.54 |
chr8_40331244_40331525 | 7.60 |
Micu3 |
mitochondrial calcium uptake family, member 3 |
22919 |
0.16 |
chr5_135008603_135009268 | 7.60 |
Abhd11 |
abhydrolase domain containing 11 |
217 |
0.79 |
chr9_37177686_37177862 | 7.58 |
Gm25273 |
predicted gene, 25273 |
4780 |
0.14 |
chr12_3237774_3237992 | 7.51 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
1272 |
0.39 |
chr16_47059984_47060135 | 7.50 |
Gm6912 |
predicted gene 6912 |
14139 |
0.31 |
chr9_98033133_98033749 | 7.49 |
Clstn2 |
calsyntenin 2 |
260 |
0.94 |
chr5_82103524_82103675 | 7.49 |
1700008H02Rik |
RIKEN cDNA 1700008H02 gene |
17763 |
0.23 |
chr2_59600550_59600735 | 7.45 |
Tanc1 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
11400 |
0.23 |
chr4_3051990_3053232 | 7.40 |
Gm27878 |
predicted gene, 27878 |
792 |
0.7 |
chr5_25222715_25223033 | 7.38 |
Galnt11 |
polypeptide N-acetylgalactosaminyltransferase 11 |
8 |
0.8 |
chr17_9879654_9879852 | 7.36 |
Gm49808 |
predicted gene, 49808 |
15334 |
0.19 |
chr7_126897934_126898711 | 7.36 |
Tmem219 |
transmembrane protein 219 |
41 |
0.92 |
chr15_33687794_33687983 | 7.32 |
Tspyl5 |
testis-specific protein, Y-encoded-like 5 |
4 |
0.98 |
chr18_81830833_81831208 | 7.30 |
Gm30454 |
predicted gene, 30454 |
18996 |
0.19 |
chr13_19622971_19623817 | 7.30 |
Sfrp4 |
secreted frizzled-related protein 4 |
219 |
0.92 |
chr16_29682710_29682901 | 7.29 |
Opa1 |
OPA1, mitochondrial dynamin like GTPase |
66180 |
0.11 |
chr7_48963195_48963421 | 7.28 |
Nav2 |
neuron navigator 2 |
4211 |
0.2 |
chr1_63273137_63273298 | 7.27 |
Zdbf2 |
zinc finger, DBF-type containing 2 |
48 |
0.42 |
chr3_145292206_145292951 | 7.26 |
Col24a1 |
collagen, type XXIV, alpha 1 |
51 |
0.98 |
chr10_118121607_118122166 | 7.26 |
5330439M10Rik |
RIKEN cDNA 5330439M10 gene |
9369 |
0.16 |
chr4_155345224_155345890 | 7.26 |
Prkcz |
protein kinase C, zeta |
175 |
0.92 |
chr17_35776840_35777207 | 7.25 |
4833427F10Rik |
RIKEN cDNA 4833427F10 gene |
4573 |
0.09 |
chr19_11770210_11770497 | 7.23 |
Mrpl16 |
mitochondrial ribosomal protein L16 |
38 |
0.95 |
chr7_70331040_70331229 | 7.17 |
Gm29683 |
predicted gene, 29683 |
6688 |
0.14 |
chr18_43279770_43279957 | 7.13 |
Stk32a |
serine/threonine kinase 32A |
21259 |
0.21 |
chr16_37938714_37939016 | 7.13 |
Gpr156 |
G protein-coupled receptor 156 |
22369 |
0.15 |
chr18_22343488_22344114 | 7.12 |
Asxl3 |
additional sex combs like 3, transcriptional regulator |
445 |
0.91 |
chr5_143247658_143247809 | 7.11 |
Zfp12 |
zinc finger protein 12 |
7694 |
0.09 |
chr8_35616031_35616182 | 7.10 |
Mfhas1 |
malignant fibrous histiocytoma amplified sequence 1 |
8829 |
0.2 |
chr18_23041229_23042141 | 7.09 |
Nol4 |
nucleolar protein 4 |
32 |
0.99 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
22.1 | 154.9 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
8.3 | 24.8 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
3.2 | 9.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
2.9 | 8.8 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
2.8 | 8.3 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
2.6 | 7.9 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
2.5 | 9.9 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
2.5 | 17.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
2.4 | 7.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
2.3 | 23.4 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
2.3 | 7.0 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
2.3 | 6.9 | GO:0046684 | response to pyrethroid(GO:0046684) |
2.2 | 6.6 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
2.0 | 6.1 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
2.0 | 6.0 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
1.9 | 5.7 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
1.8 | 7.4 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
1.8 | 11.0 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
1.8 | 7.3 | GO:0060591 | chondroblast differentiation(GO:0060591) |
1.7 | 5.2 | GO:0051182 | coenzyme transport(GO:0051182) |
1.6 | 6.2 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.5 | 4.5 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
1.5 | 6.0 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
1.5 | 5.8 | GO:0030035 | microspike assembly(GO:0030035) |
1.4 | 7.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
1.4 | 5.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.4 | 6.9 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
1.4 | 1.4 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
1.4 | 4.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
1.4 | 6.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.4 | 1.4 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
1.3 | 4.0 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
1.3 | 20.4 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
1.2 | 5.0 | GO:0060174 | limb bud formation(GO:0060174) |
1.2 | 3.6 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
1.2 | 6.0 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
1.2 | 2.4 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
1.2 | 3.6 | GO:0060594 | mammary gland specification(GO:0060594) |
1.2 | 4.6 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
1.1 | 1.1 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.1 | 3.4 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.1 | 10.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
1.1 | 2.2 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
1.1 | 3.3 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
1.1 | 4.3 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.1 | 3.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.1 | 3.2 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.1 | 2.1 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.0 | 3.0 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.0 | 3.0 | GO:0030070 | insulin processing(GO:0030070) |
1.0 | 1.0 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.0 | 5.8 | GO:0016264 | gap junction assembly(GO:0016264) |
1.0 | 3.8 | GO:0007412 | axon target recognition(GO:0007412) |
1.0 | 6.7 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.9 | 0.9 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.9 | 4.7 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.9 | 1.9 | GO:0021564 | vagus nerve development(GO:0021564) |
0.9 | 1.9 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.9 | 1.9 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.9 | 2.8 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.9 | 3.6 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.9 | 4.6 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.9 | 2.7 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.9 | 7.9 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.9 | 8.8 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.9 | 2.6 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.9 | 3.4 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.8 | 8.3 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.8 | 6.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.8 | 5.8 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.8 | 5.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.8 | 2.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.8 | 2.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.8 | 4.0 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.8 | 3.2 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.8 | 2.4 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.8 | 1.6 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.8 | 2.3 | GO:0048382 | mesendoderm development(GO:0048382) |
0.8 | 3.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.8 | 0.8 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.8 | 5.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.8 | 7.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.8 | 3.0 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.8 | 5.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.8 | 2.3 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.7 | 2.2 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.7 | 5.9 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.7 | 3.7 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.7 | 6.6 | GO:0060539 | diaphragm development(GO:0060539) |
0.7 | 1.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.7 | 7.8 | GO:0060013 | righting reflex(GO:0060013) |
0.7 | 5.7 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.7 | 2.1 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.7 | 8.2 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.7 | 2.1 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.7 | 21.2 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.7 | 4.8 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.7 | 2.0 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.7 | 2.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.7 | 2.0 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.7 | 1.3 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.6 | 2.6 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.6 | 1.9 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.6 | 2.5 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.6 | 1.9 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.6 | 1.9 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.6 | 2.5 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.6 | 1.8 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.6 | 1.8 | GO:0015889 | cobalamin transport(GO:0015889) |
0.6 | 8.5 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.6 | 1.8 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.6 | 1.2 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.6 | 27.5 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.6 | 0.6 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.6 | 2.4 | GO:0060318 | regulation of definitive erythrocyte differentiation(GO:0010724) definitive erythrocyte differentiation(GO:0060318) |
0.6 | 1.8 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.6 | 1.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.6 | 2.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.6 | 1.1 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.6 | 4.0 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.6 | 2.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.6 | 1.7 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.6 | 0.6 | GO:0046122 | dGTP metabolic process(GO:0046070) purine deoxyribonucleoside metabolic process(GO:0046122) |
0.6 | 1.7 | GO:0033058 | directional locomotion(GO:0033058) |
0.5 | 4.9 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.5 | 2.1 | GO:0030432 | peristalsis(GO:0030432) |
0.5 | 19.1 | GO:0060612 | adipose tissue development(GO:0060612) |
0.5 | 9.0 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.5 | 2.1 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.5 | 2.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.5 | 1.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.5 | 1.5 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.5 | 2.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.5 | 3.5 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.5 | 3.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.5 | 1.5 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.5 | 1.5 | GO:1902570 | protein localization to nucleolus(GO:1902570) regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.5 | 2.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.5 | 0.5 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.5 | 1.9 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.5 | 1.4 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.5 | 0.9 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.5 | 1.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.5 | 6.8 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.5 | 0.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.4 | 0.4 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.4 | 4.0 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.4 | 9.8 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.4 | 0.4 | GO:0060166 | olfactory pit development(GO:0060166) |
0.4 | 1.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.4 | 1.3 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.4 | 0.8 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.4 | 0.8 | GO:0060967 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
0.4 | 1.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.4 | 1.6 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.4 | 0.8 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.4 | 2.0 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.4 | 14.7 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.4 | 0.4 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.4 | 2.4 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.4 | 0.8 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.4 | 1.6 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.4 | 2.7 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.4 | 3.9 | GO:0001553 | luteinization(GO:0001553) |
0.4 | 1.5 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.4 | 5.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.4 | 0.8 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.4 | 1.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.4 | 1.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.4 | 0.7 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.4 | 1.8 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.4 | 7.3 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.4 | 1.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.4 | 2.2 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.4 | 1.4 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.4 | 3.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.4 | 1.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.4 | 0.4 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.4 | 1.1 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.4 | 4.9 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.3 | 0.7 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.3 | 2.8 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.3 | 2.4 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 3.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 1.4 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.3 | 1.0 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.3 | 2.4 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.3 | 1.4 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 4.4 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.3 | 1.7 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 2.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.3 | 1.7 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.3 | 1.3 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 2.3 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.3 | 1.0 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 0.3 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.3 | 1.0 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.3 | 1.3 | GO:0014028 | notochord formation(GO:0014028) |
0.3 | 4.2 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.3 | 1.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.3 | 0.3 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.3 | 16.0 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.3 | 1.2 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.3 | 0.6 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.3 | 0.6 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.3 | 2.1 | GO:0042148 | strand invasion(GO:0042148) |
0.3 | 0.6 | GO:0035973 | aggrephagy(GO:0035973) |
0.3 | 3.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.3 | 0.3 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.3 | 3.9 | GO:0006862 | nucleotide transport(GO:0006862) |
0.3 | 3.0 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.3 | 2.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.3 | 0.6 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.3 | 0.3 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.3 | 0.6 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.3 | 0.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 0.9 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
0.3 | 3.7 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.3 | 1.7 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.3 | 3.7 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.3 | 3.7 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.3 | 1.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.3 | 0.6 | GO:0070842 | aggresome assembly(GO:0070842) |
0.3 | 0.3 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.3 | 3.9 | GO:0035196 | production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
0.3 | 3.0 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.3 | 0.8 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.3 | 1.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 2.2 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.3 | 1.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.3 | 0.8 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.3 | 1.9 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.3 | 2.2 | GO:1901020 | negative regulation of calcium ion transmembrane transporter activity(GO:1901020) |
0.3 | 0.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.3 | 1.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.3 | 4.3 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.3 | 4.0 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.3 | 1.9 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.3 | 0.3 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
0.3 | 0.3 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.3 | 0.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.3 | 6.1 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.3 | 1.1 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.3 | 0.5 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.3 | 0.5 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.3 | 0.5 | GO:0035106 | operant conditioning(GO:0035106) |
0.3 | 1.3 | GO:0051639 | actin filament network formation(GO:0051639) |
0.3 | 3.4 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.3 | 3.3 | GO:0097320 | membrane tubulation(GO:0097320) |
0.3 | 1.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.3 | 0.3 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.3 | 0.3 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.3 | 0.8 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.3 | 13.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 1.3 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.2 | 1.0 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.2 | 1.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 1.0 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.2 | 1.9 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 1.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.7 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.2 | 1.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 0.2 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 0.5 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.2 | 3.1 | GO:0030033 | microvillus assembly(GO:0030033) |
0.2 | 0.2 | GO:0071838 | cell proliferation in bone marrow(GO:0071838) regulation of cell proliferation in bone marrow(GO:0071863) positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.2 | 0.5 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.2 | 0.7 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 0.9 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.2 | 3.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 | 0.5 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 0.7 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 0.5 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.2 | 0.4 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.2 | 1.3 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.2 | 1.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 0.2 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.2 | 0.7 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.2 | 1.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.2 | 1.6 | GO:0046218 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.2 | 1.6 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 1.5 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.2 | 0.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.2 | 0.7 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.2 | 0.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.7 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 6.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.2 | 0.2 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.2 | 0.6 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.2 | 0.9 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.2 | 2.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.2 | 0.2 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.2 | 0.2 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.2 | 0.8 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.2 | 0.2 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.2 | 0.6 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.2 | 2.1 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.2 | 1.4 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.2 | 0.4 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.2 | 1.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.2 | 0.4 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
0.2 | 0.6 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 0.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.8 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 0.8 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.2 | 0.8 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 0.6 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.2 | 0.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 0.4 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
0.2 | 1.0 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.2 | 0.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 2.7 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.2 | 1.2 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.2 | 1.0 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.2 | 0.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 0.2 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.2 | 0.6 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.2 | 0.2 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.2 | 0.9 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.4 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 0.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.2 | 1.5 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.2 | 0.2 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.2 | 0.4 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.2 | 1.5 | GO:0001759 | organ induction(GO:0001759) |
0.2 | 0.7 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.2 | 0.2 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.2 | 3.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 4.0 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.2 | 2.5 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.2 | 3.1 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.2 | 0.7 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.2 | 0.2 | GO:0051665 | membrane raft localization(GO:0051665) |
0.2 | 0.7 | GO:0010694 | regulation of alkaline phosphatase activity(GO:0010692) positive regulation of alkaline phosphatase activity(GO:0010694) |
0.2 | 0.5 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 1.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.5 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 0.5 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 0.7 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.2 | 0.8 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.2 | 0.3 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.2 | 0.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 0.8 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.2 | 0.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 1.0 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 0.7 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 0.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 0.5 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.2 | 0.6 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 0.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 0.2 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.2 | 0.5 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 0.2 | GO:0072034 | renal vesicle induction(GO:0072034) ureter morphogenesis(GO:0072197) |
0.2 | 1.6 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.2 | 0.2 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.2 | 0.2 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.2 | 0.6 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 1.4 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 0.5 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.2 | 0.6 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 2.4 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.4 | GO:0071839 | apoptotic process in bone marrow(GO:0071839) regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.1 | 1.8 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 7.7 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.3 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 0.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.3 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.1 | 0.4 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.1 | 1.0 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.1 | 0.6 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.3 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.1 | 0.3 | GO:0070340 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.1 | 2.0 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.1 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.4 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.1 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.1 | 0.7 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 1.1 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 0.3 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.1 | 0.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.1 | 0.3 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.1 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.3 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.8 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.9 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.4 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.3 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.6 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.4 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.1 | 0.3 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.1 | 0.3 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.1 | 0.5 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.1 | 0.3 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.2 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.1 | 0.6 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.9 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.1 | 0.4 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.1 | 0.1 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.1 | 0.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 1.0 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.2 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.1 | 1.3 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 | 0.1 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 0.4 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.1 | 0.4 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 7.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.4 | GO:0071435 | potassium ion export(GO:0071435) |
0.1 | 0.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 0.3 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.1 | 0.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.6 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.1 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.1 | 0.2 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 0.3 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.1 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 0.7 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.1 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 1.2 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 1.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.2 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.1 | 0.3 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.1 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.1 | 0.4 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.1 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.1 | 0.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 2.7 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.4 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 2.0 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 1.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.4 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.1 | 0.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 1.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 1.1 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.3 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.4 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 1.0 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.3 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.1 | 0.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.2 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.2 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.1 | 0.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.1 | 0.2 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 0.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 1.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.4 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 1.0 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.1 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.1 | 0.5 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 1.1 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 0.8 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 0.5 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.4 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.1 | 0.4 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 0.8 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.4 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 0.2 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.1 | 0.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.4 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 2.4 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.4 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 0.4 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 0.4 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.5 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.2 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.1 | 0.1 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.1 | 0.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.1 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.1 | 0.4 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.4 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 1.2 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.3 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 0.4 | GO:0060068 | vagina development(GO:0060068) |
0.1 | 0.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.4 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.3 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.1 | 0.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.3 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.2 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.2 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.3 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.1 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.6 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.2 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.3 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 1.3 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.1 | 0.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.7 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.2 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.1 | 0.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 2.4 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.2 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.1 | 0.1 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.1 | 0.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.2 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.1 | 0.2 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.2 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 0.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.2 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.1 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.3 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 0.4 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.1 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.1 | 1.2 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.3 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.2 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.1 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.4 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.1 | 0.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.3 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.1 | 0.3 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.1 | 0.3 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 3.0 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 0.4 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.1 | 0.1 | GO:1903431 | positive regulation of cell maturation(GO:1903431) |
0.1 | 0.6 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.1 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 1.2 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 1.5 | GO:0048565 | digestive tract development(GO:0048565) |
0.1 | 0.1 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.1 | 0.2 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.1 | 0.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.8 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.1 | GO:0060897 | neural plate regionalization(GO:0060897) |
0.1 | 0.3 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.1 | 0.3 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.1 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.3 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.3 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.1 | 0.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.1 | GO:0032528 | microvillus organization(GO:0032528) |
0.1 | 0.9 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.1 | 0.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.4 | GO:0046831 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 0.1 | GO:1902548 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.1 | 0.1 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 0.1 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 0.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.1 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.1 | 0.2 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.1 | 0.7 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.1 | GO:0072217 | negative regulation of metanephros development(GO:0072217) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.8 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 0.7 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.3 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.3 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 0.1 | GO:0033083 | regulation of immature T cell proliferation(GO:0033083) negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 0.1 | GO:0061548 | ganglion development(GO:0061548) |
0.1 | 0.2 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.2 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.1 | 0.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 0.2 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.1 | 0.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.1 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.1 | 0.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 0.4 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.1 | 0.2 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.1 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.1 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.1 | 0.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 0.3 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.2 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.2 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.1 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.1 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 2.2 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.1 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.1 | 2.3 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.2 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.1 | 0.1 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.3 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.1 | GO:0032196 | transposition(GO:0032196) |
0.1 | 0.1 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.1 | 0.3 | GO:0009074 | aromatic amino acid family catabolic process(GO:0009074) |
0.1 | 0.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.1 | GO:0043921 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.1 | 0.1 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.1 | 0.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.1 | 0.3 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.2 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.1 | 0.1 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.2 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 0.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.1 | 0.1 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.2 | GO:0097531 | mast cell migration(GO:0097531) |
0.1 | 0.2 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 0.1 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 | 0.2 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.6 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.1 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.1 | 0.2 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.3 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.1 | 0.2 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.0 | 0.0 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.1 | GO:0044838 | cell quiescence(GO:0044838) |
0.0 | 0.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.0 | 0.8 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.1 | GO:1904888 | cranial skeletal system development(GO:1904888) |
0.0 | 0.0 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.0 | 0.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 1.0 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 1.0 | GO:0048278 | vesicle docking(GO:0048278) |
0.0 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 0.5 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.8 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.0 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.0 | 0.1 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 3.0 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 0.0 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.0 | 0.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.0 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.0 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.3 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.0 | 0.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.0 | 2.9 | GO:0008154 | actin polymerization or depolymerization(GO:0008154) |
0.0 | 0.5 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.0 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.0 | 0.2 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.0 | 1.5 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.2 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.0 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.2 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.0 | 0.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.4 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.3 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.2 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.0 | 0.1 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
0.0 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.0 | 0.2 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.0 | GO:0031620 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
0.0 | 0.1 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.0 | 0.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.2 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.0 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 1.1 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.0 | 0.0 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.3 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.0 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.0 | 0.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 1.2 | GO:0060021 | palate development(GO:0060021) |
0.0 | 0.1 | GO:0060343 | trabecula formation(GO:0060343) |
0.0 | 0.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 0.2 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.4 | GO:0048806 | genitalia development(GO:0048806) |
0.0 | 0.0 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.0 | 0.3 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.0 | 0.0 | GO:0030421 | defecation(GO:0030421) |
0.0 | 0.1 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.0 | 0.1 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.0 | 0.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 | 0.1 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.0 | 0.1 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.0 | 0.0 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.0 | 0.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 0.0 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
0.0 | 0.7 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.0 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.0 | 0.0 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.0 | 0.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.1 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.0 | 0.4 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
0.0 | 0.1 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.0 | 1.8 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.0 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.0 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.6 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.0 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.0 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.0 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.0 | 0.1 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.0 | 0.0 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.0 | 0.1 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.0 | 0.0 | GO:0072506 | phosphate ion homeostasis(GO:0055062) trivalent inorganic anion homeostasis(GO:0072506) |
0.0 | 0.1 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.0 | 0.1 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.0 | 0.0 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.0 | 0.1 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.0 | 0.0 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.0 | 0.1 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.1 | GO:0060581 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.0 | 0.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.1 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.0 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 | 0.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.1 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.0 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
0.0 | 0.2 | GO:1900113 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.1 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.0 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.1 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.0 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.0 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.1 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.0 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.5 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.0 | GO:0036394 | amylase secretion(GO:0036394) |
0.0 | 0.1 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.0 | 0.1 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.0 | 0.3 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.0 | 0.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.1 | GO:1902751 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 0.0 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.0 | 0.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.0 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.0 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.1 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.0 | 0.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.0 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.0 | 0.0 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.0 | 0.3 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.1 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.0 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.6 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.0 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.0 | GO:0034633 | retinol transport(GO:0034633) vitamin transmembrane transport(GO:0035461) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.0 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.1 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.0 | 0.2 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.2 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.0 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.0 | 0.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.2 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.0 | 0.1 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.0 | 0.0 | GO:0060571 | morphogenesis of an epithelial fold(GO:0060571) |
0.0 | 0.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.0 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.0 | 0.2 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.0 | 0.1 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 | 0.0 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 0.0 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.0 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
0.0 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.0 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.1 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.0 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.0 | 0.0 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.0 | 0.0 | GO:0010460 | positive regulation of heart rate(GO:0010460) |
0.0 | 0.1 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.0 | 0.1 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.0 | 0.2 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.0 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.0 | 0.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.0 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.1 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.1 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.0 | GO:0021783 | preganglionic parasympathetic fiber development(GO:0021783) |
0.0 | 0.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.1 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.0 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.0 | 0.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.1 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.0 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.0 | 0.1 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.0 | 0.1 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.0 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.0 | 0.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.0 | GO:0070339 | response to bacterial lipoprotein(GO:0032493) response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.0 | 0.0 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.0 | GO:0072074 | kidney mesenchyme development(GO:0072074) |
0.0 | 0.0 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.0 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.0 | 0.0 | GO:0071898 | transcriptional activation by promoter-enhancer looping(GO:0071733) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.0 | 0.0 | GO:0003283 | atrial septum development(GO:0003283) |
0.0 | 0.0 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.0 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.0 | 0.1 | GO:0036376 | sodium ion export from cell(GO:0036376) |
0.0 | 0.0 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.0 | 0.0 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.0 | 0.0 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.0 | 0.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.0 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.0 | 0.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.0 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.0 | 0.0 | GO:0002839 | positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) |
0.0 | 0.0 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.0 | 0.0 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.0 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.0 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.0 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.0 | GO:0032439 | endosome localization(GO:0032439) |
0.0 | 0.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.1 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.0 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.0 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 32.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
2.4 | 14.2 | GO:0005915 | zonula adherens(GO:0005915) |
2.1 | 8.2 | GO:0042583 | chromaffin granule(GO:0042583) |
2.0 | 6.1 | GO:0044393 | microspike(GO:0044393) |
1.3 | 16.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.3 | 5.0 | GO:1990716 | axonemal central apparatus(GO:1990716) |
1.1 | 6.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.1 | 4.4 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.1 | 3.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.0 | 6.7 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.9 | 4.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.8 | 3.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.8 | 2.5 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.8 | 6.5 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.8 | 5.7 | GO:0071437 | invadopodium(GO:0071437) |
0.8 | 6.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.8 | 2.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.7 | 2.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.7 | 2.0 | GO:0032280 | symmetric synapse(GO:0032280) |
0.7 | 1.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.7 | 10.0 | GO:0031045 | dense core granule(GO:0031045) |
0.7 | 3.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.6 | 4.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.6 | 5.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.6 | 3.0 | GO:0000235 | astral microtubule(GO:0000235) |
0.6 | 3.6 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.6 | 1.8 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.6 | 4.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.6 | 1.8 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.6 | 1.8 | GO:1990393 | 3M complex(GO:1990393) |
0.6 | 2.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.6 | 1.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.6 | 5.5 | GO:0031527 | filopodium membrane(GO:0031527) |
0.5 | 3.0 | GO:0002177 | manchette(GO:0002177) |
0.5 | 2.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.5 | 4.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.5 | 1.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.5 | 6.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.5 | 3.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.5 | 2.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.4 | 3.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.4 | 6.6 | GO:0030673 | axolemma(GO:0030673) |
0.4 | 2.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.4 | 0.9 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.4 | 5.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.4 | 2.1 | GO:0008091 | spectrin(GO:0008091) |
0.4 | 1.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 12.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.4 | 0.4 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.4 | 2.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.4 | 2.4 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.4 | 8.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 4.1 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.4 | 2.9 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.4 | 1.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 1.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.3 | 2.7 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.3 | 1.0 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.3 | 1.3 | GO:0000125 | PCAF complex(GO:0000125) |
0.3 | 1.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.3 | 2.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 1.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 2.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 2.7 | GO:0043194 | axon initial segment(GO:0043194) |
0.3 | 3.6 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.3 | 0.9 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.3 | 2.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.3 | 0.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.3 | 0.9 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 1.5 | GO:0000805 | X chromosome(GO:0000805) |
0.3 | 0.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 15.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.3 | 2.8 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 1.1 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.3 | 1.7 | GO:0032584 | growth cone membrane(GO:0032584) |
0.3 | 1.4 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.3 | 2.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 0.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.3 | 2.1 | GO:0036157 | outer dynein arm(GO:0036157) |
0.3 | 1.3 | GO:0033503 | HULC complex(GO:0033503) |
0.3 | 0.8 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.3 | 1.5 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 2.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 1.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 0.7 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 5.6 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 11.8 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 5.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 1.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 0.7 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 3.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 0.6 | GO:0033010 | paranodal junction(GO:0033010) |
0.2 | 10.1 | GO:0072686 | mitotic spindle(GO:0072686) |
0.2 | 0.6 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 0.8 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 1.0 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.2 | 0.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 0.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 0.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 2.8 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 0.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 6.5 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 0.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 1.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 2.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 0.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 2.9 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 0.5 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 8.2 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 1.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 23.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 0.8 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 0.7 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 1.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 0.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.2 | 1.0 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 1.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 1.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 2.8 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.6 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 2.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 1.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.7 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 1.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 0.4 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 0.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.5 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 10.6 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 1.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 4.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 2.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 1.2 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.4 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 3.2 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 1.2 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.1 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 2.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.1 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.1 | 4.9 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 2.0 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 0.9 | GO:0036452 | ESCRT complex(GO:0036452) |
0.1 | 1.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 2.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 3.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 2.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 0.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 1.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.8 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.6 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.2 | GO:0042612 | MHC protein complex(GO:0042611) MHC class I protein complex(GO:0042612) |
0.1 | 0.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 1.0 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 3.8 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.9 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 1.0 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.1 | 0.3 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.2 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.5 | GO:0071010 | prespliceosome(GO:0071010) |
0.1 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 1.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 0.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.3 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.5 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.1 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.1 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.0 | 0.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.0 | 0.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.0 | 0.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 2.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.0 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 3.6 | GO:0043292 | contractile fiber(GO:0043292) |
0.0 | 0.1 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.0 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 4.3 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 0.1 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 0.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.7 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 0.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.1 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.0 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.2 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.1 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 0.1 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 1.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 4.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.0 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 0.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 0.0 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.0 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 2.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 65.2 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.0 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.1 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 20.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
3.2 | 16.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
2.9 | 8.7 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
2.6 | 12.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.1 | 6.4 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
2.1 | 6.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
2.0 | 25.9 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
1.9 | 5.8 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.7 | 6.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.5 | 6.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
1.4 | 122.4 | GO:0004896 | cytokine receptor activity(GO:0004896) |
1.4 | 4.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.3 | 6.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
1.2 | 3.7 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.2 | 3.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.2 | 3.6 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.2 | 3.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
1.2 | 9.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
1.1 | 4.6 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.1 | 14.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.1 | 3.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
1.0 | 5.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
1.0 | 8.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.0 | 3.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.0 | 3.9 | GO:0030619 | U1 snRNA binding(GO:0030619) |
1.0 | 3.9 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.9 | 14.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.9 | 2.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.9 | 2.6 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.8 | 4.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.8 | 2.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.8 | 3.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.8 | 15.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.8 | 5.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.8 | 4.0 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.8 | 3.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.7 | 2.9 | GO:0042731 | PH domain binding(GO:0042731) |
0.7 | 3.6 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.7 | 2.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.7 | 4.8 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.7 | 5.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.7 | 7.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.7 | 5.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.7 | 5.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.7 | 11.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.6 | 3.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.6 | 3.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.6 | 11.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.6 | 4.4 | GO:0043495 | protein anchor(GO:0043495) |
0.6 | 1.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.6 | 4.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.6 | 2.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.6 | 2.4 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.6 | 1.7 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.6 | 0.6 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.5 | 4.8 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.5 | 2.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.5 | 4.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.5 | 1.0 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.5 | 1.5 | GO:0051425 | PTB domain binding(GO:0051425) |
0.5 | 0.5 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.5 | 0.5 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.5 | 3.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.5 | 1.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.5 | 11.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.5 | 6.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.5 | 20.4 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.5 | 1.8 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.5 | 1.4 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.4 | 0.4 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.4 | 2.7 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.4 | 1.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.4 | 1.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.4 | 7.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.4 | 0.8 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.4 | 1.7 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.4 | 1.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 4.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 1.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 2.0 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.4 | 9.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.4 | 8.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.4 | 6.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.4 | 0.4 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.4 | 3.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.4 | 10.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.4 | 2.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.4 | 4.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.4 | 4.3 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.4 | 2.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.4 | 0.4 | GO:0038191 | neuropilin binding(GO:0038191) |
0.4 | 4.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.3 | 1.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.3 | 1.0 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.3 | 2.4 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.3 | 1.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 3.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 1.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 5.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 1.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.3 | 1.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.3 | 4.0 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.3 | 0.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 0.9 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.3 | 1.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.3 | 2.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.3 | 1.5 | GO:1990254 | keratin filament binding(GO:1990254) |
0.3 | 0.9 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 1.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 0.9 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.3 | 0.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 3.6 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.3 | 2.5 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.3 | 1.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 0.8 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.3 | 1.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 0.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.3 | 1.9 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.3 | 14.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.3 | 1.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 1.3 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.3 | 0.3 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.2 | 1.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 1.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 1.0 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.2 | 6.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 0.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 0.9 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 3.5 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 1.4 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 0.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.2 | 0.7 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 0.2 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.2 | 12.2 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 0.6 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 4.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 1.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 4.0 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 0.6 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 1.3 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.2 | 0.6 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.2 | 1.0 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 1.9 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 0.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 1.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 0.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 1.6 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 47.1 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.2 | 1.3 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 3.6 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.2 | 5.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 3.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 1.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 0.7 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 1.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 0.4 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 0.7 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.2 | 1.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 1.6 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 3.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.5 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.2 | 1.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.2 | 0.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 2.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 0.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 0.5 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 3.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 0.5 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 0.5 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.2 | 0.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 0.5 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 0.5 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 0.6 | GO:0036033 | mediator complex binding(GO:0036033) |
0.2 | 0.5 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 0.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 0.8 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 0.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 0.6 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.2 | 0.9 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 13.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 1.0 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 0.6 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 3.4 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.1 | 1.4 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 1.4 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.6 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 8.7 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.8 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 3.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 1.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.3 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.1 | 5.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 2.8 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 1.0 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 0.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 1.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 2.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.3 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 0.4 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.6 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 3.4 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.4 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.8 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.7 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.5 | GO:0052717 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.1 | 0.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 1.2 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.3 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.4 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 0.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 1.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.3 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 3.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.3 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.5 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.1 | 0.5 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.6 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.8 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 0.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.4 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 1.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 1.7 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 3.0 | GO:0043907 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.1 | 1.2 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 3.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 1.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 2.0 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.1 | 0.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 11.0 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 6.6 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 0.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 4.6 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.1 | 0.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.4 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 0.3 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 4.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 3.8 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.3 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.3 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.1 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.1 | 0.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.5 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 1.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 1.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.4 | GO:0046030 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.1 | 3.7 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.6 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.3 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.3 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 5.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 5.8 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.1 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.6 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.4 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.9 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.1 | 0.1 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 0.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.3 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 2.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 1.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.9 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 1.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 3.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.2 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.3 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.3 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.0 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 2.2 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 3.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 1.3 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.7 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.6 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.3 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.1 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.0 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.3 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 4.6 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.0 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.0 | 0.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.0 | 0.0 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.1 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.0 | 0.1 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.2 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 0.1 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.3 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.1 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.0 | 0.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.0 | 0.1 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.0 | 0.3 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.0 | 0.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.0 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.0 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.2 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.0 | 0.0 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 0.2 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.5 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.0 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.0 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.0 | 0.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.1 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.0 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.0 | 0.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.0 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.0 | 0.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.0 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.3 | GO:0045543 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.0 | 0.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.0 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.3 | 152.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
1.1 | 17.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.5 | 7.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.5 | 10.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.5 | 9.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.5 | 16.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.4 | 7.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 5.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 7.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 7.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 11.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 10.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 2.5 | ST ADRENERGIC | Adrenergic Pathway |
0.3 | 0.8 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 5.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 5.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 2.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 9.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 1.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 0.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 3.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 2.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 6.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 1.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 1.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 1.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 2.9 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 2.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.8 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 1.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 2.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 2.3 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 4.0 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 2.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 1.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 2.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 1.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 2.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.5 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 3.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 1.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 2.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 0.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 2.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 123.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
1.8 | 18.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
1.6 | 17.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.8 | 17.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.7 | 7.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.5 | 7.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.4 | 10.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.4 | 9.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 3.9 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.4 | 0.4 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.4 | 5.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 3.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.4 | 3.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.4 | 7.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.3 | 4.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 3.8 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.3 | 2.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 3.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.3 | 4.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.3 | 0.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.3 | 3.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.3 | 2.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.3 | 2.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 3.0 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.3 | 5.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 3.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 8.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 2.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 4.6 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 9.9 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.2 | 2.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 2.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 1.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 2.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 3.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 1.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.2 | 3.6 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.2 | 2.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.2 | 3.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 2.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 2.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 1.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 5.9 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 0.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 3.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 1.2 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 4.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 1.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 1.6 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 3.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 1.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 1.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 5.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.6 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 2.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 1.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 2.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 1.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 4.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 2.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 1.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 3.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 0.8 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 0.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 3.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 2.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.1 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.1 | 3.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 1.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.4 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 0.1 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.5 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 1.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.1 | REACTOME INNATE IMMUNE SYSTEM | Genes involved in Innate Immune System |
0.0 | 0.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.8 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 1.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.0 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.0 | 0.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.1 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.0 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.0 | 0.0 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.0 | 0.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.0 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.5 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.0 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.0 | 0.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 2.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.3 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.9 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 1.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.1 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |